# Administrative Core

> **NIH NIH P30** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2020 · $584,560

## Abstract

ADMINISTRATIVE CORE 
ABSTRACT 
The UAB Comprehensive Cancer Center's (UAB CCC) Senior Leadership and Administrative Unit work 
collaboratively under the leadership of the Director to develop, initiate, and implement the Center's strategic 
initiatives focused on achieving the Center's research mission. 
The CCC Administrative Unit serves as the central coordinating hub of the Center's activities with the primary 
goal of meeting the needs of Center members within the strategic framework developed by the Center's 
leadership. The Administrative Unit serves the CCC and its members through: 1) acquiring, maintaining and 
reporting data for informed strategic planning and decision support; 2) coordination and implementation of 
programmatic initiatives; 3) oversight and management of Center assets and resources including financial, 
space and facility; 4) facilitating faculty recruitment, 5) administering pilot grant and research development 
program; 6) representing the Center' interests with institutional administrative entities; 7) internal and external 
communications; and 9) grants management. 
The CCC Senior Leadership supports the mission of the Center through strategic planning and evaluation, 
oversight of CCC research activities, integration of the CCC's research themes across programmatic areas, 
and establishing collaborative relationships within the CCC, UAB and HudsonAlpha as well as with external 
institutions. Specifically, the CCC Senior Leaders provide oversight and guidance to the research programs, 
shared facilities, membership, strategic themes, resource management, and undergraduate, graduate and 
post-graduate cancer research training programs. The CCC Senior Leadership is comprised of eight eminent 
oncology scientists supported by the CCSG: 
Director – Edward E. Partridge, MD 
Deputy Director – Ravi Bhatia, MD, PhD 
HudsonAlpha President and CEO- Richard Myers, PhD 
Associate Director for Basic Research – Etty (Tika) Benveniste, PhD 
Associate Director for Translational Research – Mary-Ann Bjornsti, PhD 
Associate Director for Clinical Research – Harry Erba, MD, PhD 
Associate Director for Prevention and Control – Wendy Demark-Wahnefried, PhD 
Associate Director for Drug Discovery and Development – Richard Whitley, MD 
Associate Director for Administration – Michael J. Bertram, PhD, MBA

## Key facts

- **NIH application ID:** 9895631
- **Project number:** 5P30CA013148-48
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** Barry P Sleckman
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $584,560
- **Award type:** 5
- **Project period:** — → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9895631

## Citation

> US National Institutes of Health, RePORTER application 9895631, Administrative Core (5P30CA013148-48). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9895631. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*